Skip to content
healthcare.dev

BYNFEZIA Pen

NDC 62756-452, octreotide acetate, injection, from Sun Pharmaceutical Industries, Inc..

Product NDC
62756-452
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213224
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62756-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTREOTIDE ACETATE2.5 mg/mL

Pharmacologic classes

Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]

Package NDCNDC-11Package
62756-452-36627560452361 CARTRIDGE in 1 CARTON (62756-452-36) / 2.8 mL in 1 CARTRIDGE
62756-452-37627560452372 CARTRIDGE in 1 CARTON (62756-452-37) / 2.8 mL in 1 CARTRIDGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/20ed4e79-ad4c-426f-859d-83790c00439b

Use it

Look up 62756-452 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62756-452 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62756-452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.